Published in Med Phys on January 01, 2011
Radiotherapy pre-treatment dose validation: A second verification of monitor units (MU) with a commercial software. J Med Phys (2012) 0.90
Independent calculation of monitor units for VMAT and SPORT. Med Phys (2015) 0.80
The quality assurance of volumetric modulated arc therapy (VMAT) plans for early stage prostate cancer: a technical note. J Med Radiat Sci (2014) 0.78
Clinical implementation of an electron monitor unit dosimetry system based on task group 71 report and a commercial calculation program. J Med Phys (2017) 0.75
A simple calculation method for determination of equivalent square field. J Med Phys (2012) 0.75
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry (2010) 2.54
The Radiological Physics Center's standard dataset for small field size output factors. J Appl Clin Med Phys (2012) 2.14
Accelerator beam data commissioning equipment and procedures: report of the TG-106 of the Therapy Physics Committee of the AAPM. Med Phys (2008) 1.89
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer. Lasers Surg Med (2002) 1.86
A method for determination of the absorption and scattering properties interstitially in turbid media. Phys Med Biol (2005) 1.82
A review of in-vivo optical properties of human tissues and its impact on PDT. J Biophotonics (2011) 1.78
Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling. J Biophotonics (2010) 1.71
Interstitial fluorescence spectroscopy in the human prostate during motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol (2007) 1.69
Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis (2007) 1.63
Design, development, and implementation of the radiological physics center's pelvis and thorax anthropomorphic quality assurance phantoms. Med Phys (2007) 1.56
Independent evaluations of IMRT through the use of an anthropomorphic phantom. Technol Cancer Res Treat (2006) 1.53
Energy dependence of commercially available diode detectors for in-vivo dosimetry. Med Phys (2007) 1.50
Magnitude of interfractional vaginal cuff movement: implications for external irradiation. Int J Radiat Oncol Biol Phys (2011) 1.46
Analytic function for predicting light fluence rate of circular fields on a semi-infinite turbid medium. Opt Express (2016) 1.43
Neuropsychological assessment of HIV-infected populations in international settings. Neuropsychol Rev (2009) 1.31
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res (2008) 1.26
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys and prostates. Phys Med Biol (2002) 1.23
Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt (2005) 1.22
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol (2006) 1.21
Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm. Med Phys (2005) 1.18
Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy. Photochem Photobiol Sci (2009) 1.17
Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light. Photochem Photobiol (2007) 1.17
QA for helical tomotherapy: report of the AAPM Task Group 148. Med Phys (2010) 1.16
Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing. Int J Radiat Oncol Biol Phys (2013) 1.15
Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy. Phys Med Biol (2008) 1.10
In-vivo singlet oxygen threshold doses for PDT. Photonics Lasers Med (2015) 1.05
Deformable registration of abdominal kilovoltage treatment planning CT and tomotherapy daily megavoltage CT for treatment adaptation. Med Phys (2009) 1.03
Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling. J Biomed Opt (2015) 1.03
Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate. Phys Med Biol (2008) 1.03
Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol (2007) 0.98
Reconstruction of in-vivo optical properties for human prostate using interstitial diffuse optical tomography. Opt Express (2009) 0.98
Estimation of setup uncertainty using planar and MVCT imaging for gynecologic malignancies. Int J Radiat Oncol Biol Phys (2008) 0.96
Dose rate and SDD dependence of commercially available diode detectors. Med Phys (2004) 0.95
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol (2013) 0.95
Study of tissue oxygen supply rate in a macroscopic photodynamic therapy singlet oxygen model. J Biomed Opt (2015) 0.93
Determination of optical properties in heterogeneous turbid media using a cylindrical diffusing fiber. Phys Med Biol (2012) 0.93
Report of AAPM Therapy Physics Committee Task Group 74: in-air output ratio, Sc, for megavoltage photon beams. Med Phys (2009) 0.92
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol (2007) 0.91
Dosimetric impact of Acuros XB deterministic radiation transport algorithm for heterogeneous dose calculation in lung cancer. Med Phys (2013) 0.90
Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. J Int Neuropsychol Soc (2010) 0.88
Technical note: DIRART--A software suite for deformable image registration and adaptive radiotherapy research. Med Phys (2011) 0.88
Technical note: deformable image registration on partially matched images for radiotherapy applications. Med Phys (2010) 0.87
Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation. J Acquir Immune Defic Syndr (2015) 0.86
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys (2006) 0.86
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol (2012) 0.85
Fast, low-dose patient localization on TomoTherapy via topogram registration. Med Phys (2010) 0.85
Temperature dependence of commercially available diode detectors. Med Phys (2002) 0.84
Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosis. J Biomed Opt (2007) 0.83
Image guided IMRT dosimetry using anatomy specific MOSFET configurations. J Appl Clin Med Phys (2008) 0.82
HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people. AIDS (2007) 0.81
Point/Counterpoint. Patient-specific QA for IMRT should be performed using software rather than hardware methods. Med Phys (2013) 0.81
Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials. J Appl Clin Med Phys (2013) 0.81
Ion recombination correction factors (P(ion)) for Varian TrueBeam high-dose-rate therapy beams. J Appl Clin Med Phys (2012) 0.80
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol (2011) 0.80
Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma. Photodiagnosis Photodyn Ther (2011) 0.79
Information technology resource management in radiation oncology. J Appl Clin Med Phys (2009) 0.79
Technical note: electronic chart checks in a paperless radiation therapy clinic. Med Phys (2012) 0.78
The validation of tomotherapy dose calculations in low-density lung media. Phys Med Biol (2009) 0.78
Vulvar cancer in a patient with Fanconi's anemia, treated with 3D conformal radiotherapy. Am J Hematol (2004) 0.78
Small field electron beam dosimetry using MOSFET detector. J Appl Clin Med Phys (2010) 0.78
On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling. Phys Med Biol (2017) 0.78
Modeling scatter-to-primary dose ratio for megavoltage photon beams. Med Phys (2010) 0.78
Thermal and temporal response of ionization chambers in radiation dosimetry. Med Phys (2004) 0.76
IMRT credentialing for prospective trials using institutional virtual phantoms: results of a joint European Organization for the Research and Treatment of Cancer and Radiological Physics Center project. Radiat Oncol (2014) 0.75
Comments to Garvey et al.: "Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy". HIV Clin Trials (2012) 0.75
Plasma Dickkopf-related Protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment. AIDS (2017) 0.75
Equivalency of Spanish language versions of the trail making test part B including or excluding "CH". Clin Neuropsychol (2008) 0.75
Feasibility of interstitial diffuse optical tomography using cylindrical diffusing fibers for prostate PDT. Phys Med Biol (2013) 0.75
Analytic function for predicting light fluence rate of circular fields on a semi-infinite turbid medium: erratum. Opt Express (2016) 0.75
Bengt E. Bjärngard, Ph.D. Med Phys (2014) 0.75
Measurement of in-air output ratios using different miniphantom materials. Phys Med Biol (2006) 0.75
Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection. J Acquir Immune Defic Syndr (2017) 0.75
Backscatter correction factor for megavoltage photon beam. Med Phys (2011) 0.75
In regards to Dr. Eisbruch A et al. (Int J Radiat Oncol Biol Phys 2009. Electronic publication, June 17, 2009.). Int J Radiat Oncol Biol Phys (2010) 0.75
Should image rotation be addressed during routine cone-beam CT quality assurance? Phys Med Biol (2013) 0.75
Film dosimetry in the peripheral region using multiple sensitometric curves. Med Phys (2004) 0.75
Monte Carlo simulation of the effect of miniphantom on in-air output ratio. Med Phys (2010) 0.75
Point/counterpoint. The title "radiation oncology physicist" should be changed to "oncologic physicist". Med Phys (2010) 0.75
Independent verification of transferred delivery sinogram between two dosimetrically matched helical tomotherapy machines: a protocol for patient-specific quality assurance. Phys Med Biol (2012) 0.75
Modeling the instantaneous dose rate dependence of radiation diode detectors. Med Phys (2003) 0.75
The use of exit detector sinograms to detect anatomical variations for patients extending beyond the TomoTherapy field of view: a feasibility study. Med Phys (2012) 0.75
CBCT volumetric coverage extension using a pair of complementary circular scans with complementary kV detector lateral and longitudinal offsets. Phys Med Biol (2014) 0.75
Determination of correction factors for a 2D diode array device in MV photon beams. Med Phys (2009) 0.75
Metal artifact reduction in MRI-based cervical cancer intracavitary brachytherapy. Phys Med Biol (2017) 0.75